Projected Income Statement: Amphenol Corporation

Forecast Balance Sheet: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 3,603 3,205 2,862 3,569 4,371 11,178 6,862 -2,117
Change - -11.05% -10.7% 24.7% 22.47% 155.71% -38.61% -130.85%
Announcement Date 26/01/22 25/01/23 24/01/24 22/01/25 28/01/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 360.4 383.8 372.8 665.4 996.6 1,378 1,555 1,764
Change - 6.49% -2.87% 78.49% 49.77% 38.26% 12.88% 13.42%
Free Cash Flow (FCF) 1 1,180 1,791 2,156 2,157 4,393 6,355 7,607 9,224
Change - 51.8% 20.39% 0.06% 103.65% 44.66% 19.71% 21.25%
Announcement Date 26/01/22 25/01/23 24/01/24 22/01/25 28/01/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Amphenol Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 23.64% 23.77% 23.9% 25.46% 30.19% 32.79% 32.62% 32.68%
EBIT Margin (%) 20% 20.66% 20.66% 21.69% 26.2% 28.53% 29.03% 29.21%
EBT Margin (%) 18.29% 19.55% 19.55% 19.79% 24.25% 25.38% 27.33% 27.23%
Net margin (%) 14.63% 15.07% 15.36% 15.92% 18.49% 18.41% 20.25% 20.36%
FCF margin (%) 10.85% 14.19% 17.17% 14.17% 19.02% 17.88% 18.08% 19.49%
FCF / Net Income (%) 74.16% 94.14% 111.82% 88.99% 102.87% 97.13% 89.31% 95.71%

Profitability

        
ROA 11.78% 12.43% 11.74% 12.55% 14.82% 15.68% 17.13% 17.55%
ROE 27.22% 28% 24.35% 26.27% 36.82% 41.92% 41.28% 32.65%

Financial Health

        
Leverage (Debt/EBITDA) 1.4x 1.07x 0.95x 0.92x 0.63x 0.96x 0.5x -
Debt / Free cash flow 3.05x 1.79x 1.33x 1.65x 1x 1.76x 0.9x -

Capital Intensity

        
CAPEX / Current Assets (%) 3.31% 3.04% 2.97% 4.37% 4.32% 3.88% 3.7% 3.73%
CAPEX / EBITDA (%) 14.02% 12.79% 12.42% 17.17% 14.29% 11.82% 11.34% 11.4%
CAPEX / FCF (%) 30.55% 21.43% 17.29% 30.85% 22.69% 21.68% 20.45% 19.13%

Items per share

        
Cash flow per share 1 0.6156 0.8754 1.019 1.114 2.104 3.148 3.699 4.76
Change - 42.22% 16.36% 9.34% 88.88% 49.65% 17.51% 28.67%
Dividend per Share 1 0.1588 0.2025 0.2125 0.275 0.3725 0.5719 0.5593 0.6287
Change - 27.56% 4.94% 29.41% 35.45% 53.52% -2.19% 12.41%
Book Value Per Share 1 2.519 2.824 3.505 4.049 5.468 7.467 10.2 13.3
Change - 12.13% 24.09% 15.52% 35.05% 36.57% 36.64% 30.34%
EPS 1 0.635 0.765 0.7775 0.96 1.67 2.548 3.279 3.787
Change - 20.47% 1.63% 23.47% 73.96% 52.6% 28.68% 15.47%
Nbr of stocks (in thousands) 2,392,111 2,380,378 2,393,241 2,411,226 2,448,111 2,465,967 2,465,967 2,465,967
Announcement Date 26/01/22 25/01/23 24/01/24 22/01/25 28/01/26 - - -
1USD
Estimates
2026 *2027 *
P/E 32.6x 25.3x
PBR 11.1x 8.14x
EV / Sales 6.08x 5.03x
Yield 0.69% 0.67%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
83.08USD
Average target price
99.39USD
Spread / Average Target
+19.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APH Stock
  4. Financials Amphenol Corporation